- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00918762
Transoral Robotic Surgery or Standard Surgery in Treating Patients With Benign or Malignant Tumors of the Larynx and Pharynx
A Pilot Study Assessing the Use of DA VINCI® Robotic Surgical System in Laryngeal and Pharyngeal Surgeries
RATIONALE: Transoral robotic surgery may make it easier to find and remove benign or malignant tumors of the larynx and pharynx and cause less damage to normal tissue. It is not yet known whether transoral robotic surgery is more effective than standard surgery in diagnosing and treating larynx and pharynx tumors.
PURPOSE: This phase I trial is studying how well transoral robotic surgery works compared with standard surgery in treating patients with benign or malignant tumors of the larynx or pharynx.
Studieoversikt
Status
Intervensjon / Behandling
- Fremgangsmåte: terapeutisk konvensjonell kirurgi
- Fremgangsmåte: livskvalitetsvurdering
- Fremgangsmåte: diagnostisk endoskopisk kirurgi
- Fremgangsmåte: vurdering av terapikomplikasjoner
- Fremgangsmåte: terapeutisk endoskopisk kirurgi
- Fremgangsmåte: videoassistert kirurgi
- Fremgangsmåte: transoral robotic surgery
Detaljert beskrivelse
OBJECTIVES:
Primary
- Evaluate the potential benefits of using the transoral robotic surgical approach against the conventional open and transoral approaches in patients with benign or malignant disease involving the larynx and pharynx.
Secondary
- Determine the proportion of laryngeal and pharyngeal surgical procedures where the surgical exposure is adequate to allow the successful completion of the surgical resection using the transoral robotic surgical approach.
OUTLINE: Patients are assigned to transoral robotic surgery or standard therapy consisting of conventional transoral endoscopic or open approach according to their preference.
Patients undergo planned surgical procedures (either diagnostic or therapeutic) appropriate for their disease in the larynx or pharynx via the transoral robotic surgical approach or the conventional transoral endoscopic or open approach.
Patients complete the Functional Assessment of Cancer Therapy Head and Neck Scale, the Performance Status Scale for Head and Neck Cancer Patients, and the University of Washington Quality of Life Scale at baseline and at 3 and 6 months. Patients also undergo voice analysis by acoustic analyses, and speech and swallow pathology evaluation by videostroboscopy and modified barium swallow.
After completion of study procedure, patients are followed at 3 and 6 months.
PROJECTED ACCRUAL: A total of 80 patients will be accrued to the control group (standard conventional surgery) and 30 patients will be accrued to the robotic surgery group.
Studietype
Registrering (Faktiske)
Fase
- Fase 1
Kontakter og plasseringer
Studiesteder
-
-
Michigan
-
Detroit, Michigan, Forente stater, 48201-1379
- Barbara Ann Karmanos Cancer Institute
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
DISEASE CHARACTERISTICS:
Benign or malignant disease of the larynx or pharynx that requires surgical intervention for either diagnostic or therapeutic purposes
Malignant disease must meet the following criteria:
Histologically confirmed diagnosis of 1 of the following:
- Glottic cancer (T1, T2, and T3)
- Supraglottic cancer (T1, T2, and T3)
- Hypopharyngeal cancer (T1 and T2)
- Oropharyngeal cancer (T1, T2, and T3)
- Nasopharyngeal cancer (T1 and T2)
- Resectable involved lymph nodes
No invasion of osseous and/or osseocartilaginous structures including the following:
- Mandibular bone
- Thyroid cartilage
- Hyoid bone
- Cricoid bone
- Vertebral body
- No pharyngeal wall or tongue-based involvement requiring resection of > 50% of the posterior pharyngeal wall or tongue base
- No radiological confirmation of carotid artery involvement
- No fixation of tumor to the prevertebral fascia
- No bilateral arytenoid involvement
- No surgical defect requiring open approach for reconstruction
- No evidence of distant metastasis
PATIENT CHARACTERISTICS:
- Not pregnant
- No unexplained fever and/or untreated active infection
- No medical conditions contraindicating general anesthesia
- No inadequate jaw opening due to prior head and neck surgery, trauma, or radiotherapy
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: daVinci® Robotic Surgical System
Participants will undergo a planned surgical procedures via the robotic approach.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
Operative time that directly affects operative cost
Tidsramme: post operative
|
post operative
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
Blodtap
Tidsramme: Under operasjonen
|
Under operasjonen
|
Intra-operative and post-operative complications
Tidsramme: during the operation and post operative
|
during the operation and post operative
|
Need for reconstruction
Tidsramme: post operative
|
post operative
|
Margins status
Tidsramme: post operative
|
post operative
|
Length of hospital stay
Tidsramme: during time as inpatient
|
during time as inpatient
|
Tracheostomy and PEG dependence
Tidsramme: post operative
|
post operative
|
Days to oral intake
Tidsramme: post operative
|
post operative
|
Time to locoregional recurrence
Tidsramme: post operative
|
post operative
|
Speech intelligibility
Tidsramme: post operative
|
post operative
|
Quality of life
Tidsramme: 3 months and 6 month following completion of surgery
|
3 months and 6 month following completion of surgery
|
Postoperative pain
Tidsramme: post operative
|
post operative
|
Proportion of robotic surgical cases where adequate surgical exposure allowed for successful operation completion
Tidsramme: post operative
|
post operative
|
Samarbeidspartnere og etterforskere
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Ho-Sheng Lin, MD, Barbara Ann Karmanos Cancer Institute
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
- stadium III plateepitelkarsinom i orofarynx
- stadium III lymfepitelom i orofarynx
- stadium III plateepitelkarsinom i nasopharynx
- stadium III lymfepitelom i nasofarynx
- stadium III plateepitelkarsinom i hypopharynx
- stadium III plateepitelkarsinom i strupehodet
- stadium III verrucous karsinom i strupehodet
- precancerøs tilstand
- stadium I plateepitelkarsinom i hypopharynx
- stadium I plateepitelkarsinom i strupehodet
- stadium I plateepitelkarsinom i nasopharynx
- stadium I plateepitelkarsinom i orofarynx
- stadium II plateepitelkarsinom i hypopharynx
- stadium II plateepitelkarsinom i strupehodet
- stadium II plateepitelkarsinom i nasopharynx
- stadium II plateepitelkarsinom i orofarynx
- perioperative/postoperative komplikasjoner
- stadium I verrucous karsinom i strupehodet
- stadium II verrucous karsinom i strupehodet
- stadium I lymfepitheliom i nasopharynx
- stadium II lymfepitheliom i nasopharynx
- stadium I lymfepitheliom i orofarynx
- stadium II lymfepitelom i orofarynx
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- CDR0000642940
- P30CA022453 (U.S. NIH-stipend/kontrakt)
- WSU-2008-022
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på terapeutisk konvensjonell kirurgi
-
Diakonessenhuis, UtrechtRekrutteringLivskvalitet | Søvnapné, obstruktivNederland
-
Boston Medical CenterHar ikke rekruttert ennåRusmisbruksforstyrrelser | Psykisk helseproblemForente stater
-
Babes-Bolyai UniversityAktiv, ikke rekrutterendeREThink Game | Behandling som vanligRomania
-
Royal Surrey County Hospital NHS Foundation TrustUkjentEggstokkreft | Egglederkreft | Peritoneal kreft | Neoplasma i eggstokkene | Ovarial neoplasma epitelialStorbritannia
-
Universidade Federal de Sao CarlosFullført
-
Grupo Español de Rehabilitación MultimodalInstituto de Salud Carlos III; Instituto de Investigación Sanitaria AragónRekruttering
-
University of Colorado, DenverRekrutteringForbedret restitusjon etter operasjon | Gynekologisk sykdomForente stater
-
ARCAGY/ GINECO GROUPRekrutteringEggstokkreft stadium IIIC | Eggstokkreft Stadium IV | Eggstokkreft stadium IIIbFrankrike
-
Bournemouth UniversityStryker Orthopaedics; Nuffield Health Bournemouth; Orthopaedic Research InstituteRekruttering
-
Ayşe ARIKAN DÖNMEZHar ikke rekruttert ennåDemens | Virtuell virkelighet | Utdanning | SykepleierstudenterTyrkia